检索结果 - Samuel C. Blackman

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial

    Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial 由 Gerald S. Falchook, Georgina V. Long, Razelle Kurzrock, Kevin B. Kim, Tobias Arkenau, Michael P. Brown, Omid Hamid, Jeffrey R. Infante, Michael Millward, Anna C. Pavlick, Steven O’Day, Samuel C. Blackman, C. Martin Curtis, Peter F. Lebowitz, Bo Ma, Danièle Ouellet, Richard Kefford

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)

    Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436) 由 Gerald S. Falchook, Georgina V. Long, Razelle Kurzrock, Kevin B. Kim, H.-Tobias Arkenau, Michael P. Brown, Omid Hamid, Jeffrey R. Infante, Michael Millward, Anna C. Pavlick, Melvin Chin, Steven O’Day, Samuel C. Blackman, C. Martin Curtis, Peter F. Lebowitz, Bo Ma, Danièle Ouellet, Richard Kefford

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors

    Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors 由 Ian E. Krop, Tim Demuth, Tina Guthrie, Patrick Y. Wen, Warren Mason, Prakash Chinnaiyan, Nicholas Butowski, Morris D. Groves, Santosh Kesari, Steven J. Freedman, Samuel C. Blackman, James Watters, Andrey Loboda, Alexei A. Podtelezhnikov, Jared Lunceford, Cong Chen, Maxine Giannotti, Jeremy Hing, Robert A. Beckman, Patricia LoRusso

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RA... 由 Cornelis M. van Tilburg, Lindsay Kilburn, Sébastien Perreault, René Schmidt, Amedeo A. Azizi, Ofelia Cruz, Michal Zápotocký, Katrin Scheinemann, Antoinette Y. N. Schouten–van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S. Ziegler, David Capper, Arend Koch, Felix Sahm, Jiaheng Qiu, Li‐Pen Tsao, Samuel C. Blackman, Peter Manley, Till Milde, Ruth Witt, David Jones, Darren Hargrave, Olaf Witt

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

    The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial 由 Lindsay Kilburn, Dong-Anh Khuong-Quang, Jordan R. Hansford, Daniel Landi, Jasper van der Lugt, Sarah Leary, Pablo Hernáiz Driever, Simon Bailey, Sébastien Perreault, Geoffrey McCowage, Angela J. Waanders, David S. Ziegler, Olaf Witt, Patricia Baxter, Hyoung Jin Kang, Tim Hassall, Jung Woo Han, Darren Hargrave, Andrea Franson, Michal Oren, Helen Toledano, Valérie Larouche, Cassie Kline, Mohamed S Abdelbaki, Nada Jabado, Nicholas G. Gottardo, Nicolas U. Gerber, Nicholas Whipple, Devorah Segal, Susan Chi, Liat Oren, Enrica Tan, Sabine Mueller, Izzy Cornelio, Lisa McLeod, Xin Zhao, Ashley A. Walter, Daniel Da Costa, Peter Manley, Samuel C. Blackman, Roger J. Packer, Karsten Nysom

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: